[1]
|
R. J. Caselli, J. F. Drazkowski and D. M. Wingerchuk, “Autoimmune Encephalopathy,” Mayo Clinic Proceedings, Vol. 85, No. 10, 2010, pp. 878-880.
|
[2]
|
G. A. Marshall and J. J. Doyle, “Long-Term Treatment of Hashimoto’s Encephalopathy,” Journal of Neuropsychiatry and Clinical Neurosciences, Vol. 18, No. 1, 2006, pp. 14-20. doi:10.1176/appi.neuropsych.18.1.14
|
[3]
|
S. Melmed, K. S. Polonsky, P. R. Larsen and H. M. Kronenberg, “Williams Textbook of Endocrinology, 12th Edition,” In: Gregory A. Brent and Terryf. Davies, Ed., Hypothyroidism and Thyroiditis, Elsevier Saunders, Inc., Philadelphia, 2011, pp. 410.
|
[4]
|
N. J. Sarlis, F. Brucker-Davis, J. L. Doppman and M. C. Skarulis, “MRI-Demonstrable Regression of a Pituitary Mass in a Case of Primary Hypothyroidism after a Week of Acute Thyroid Hormone Therapy,” Journal of Clinical Endocrinology and Metabolism, Vol. 82, No. 3, 1997, pp. 808-811.
|
[5]
|
S. Fukata, G. A. Brent and M. Sugawara, “Resistance to Thyroid Hormone in Hashimoto’s Thyroiditis,” New England Journal of Medicine, Vol. 352, No. 5, 2005, pp. 517-518.
|
[6]
|
K. W. Nolte, A. Unbehaun, H. Sieker, T. M. Kloss and W. Paulus, “Hashimoto Encephalopathy: A Brainstem Vasculitis?” Neurology, Vol. 54, No. 3, 2000, pp. 769-770.
doi:10.1212/WNL.54.3.769
|
[7]
|
J. Y. Chong, L. P. Rowland and R. D. Utiger, “Hashimoto Encephalopathy, Syndrome or Myth?” Archives of Neurology, Vol. 60, No. 2, 2003, pp. 164-171.
|
[8]
|
P. Striano, M. Pagliuca, V. Andreone, F. Zara, A. Coppola and S. Striano, “Unfavourable Outcome of Hashimoto Encephalopathy Due to Status Epilepticus: One Autopsy case,” Journal of Neurology, Vol. 253, No. 2, 2006, pp. 248-249. doi:10.1007/s00415-005-0925-6
|
[9]
|
N. Schiess and C. A. Pardo, “Hashimoto’s Encephalopathy,” Annals of the New York Academy of Sciences, Vol. 1142, 2008, pp. 254-265. doi:10.1196/annals.1444.018
|